Q: Hi there,
ABBV has been on a decent run since July. I assume their mostly positive quarterly report indicating lots of activity in their drug pipeline is one reason plus healthcare seems to be showing a bit of life.
How do you see it’s valuation is it an ADD/BUY in a diversified portfolio for growth and income?
ABBV has been on a decent run since July. I assume their mostly positive quarterly report indicating lots of activity in their drug pipeline is one reason plus healthcare seems to be showing a bit of life.
How do you see it’s valuation is it an ADD/BUY in a diversified portfolio for growth and income?